GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (NAS:OCUL) » Definitions » E10
中文

Ocular Therapeutix (Ocular Therapeutix) E10 : $-2.49 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ocular Therapeutix's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.350. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.49 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-25), Ocular Therapeutix's current stock price is $4.645. Ocular Therapeutix's E10 for the quarter that ended in Dec. 2023 was $-2.49. Ocular Therapeutix's Shiller PE Ratio of today is .


Ocular Therapeutix E10 Historical Data

The historical data trend for Ocular Therapeutix's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix E10 Chart

Ocular Therapeutix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -2.78 -2.49

Ocular Therapeutix Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.78 -2.84 -2.74 -2.61 -2.49

Competitive Comparison of Ocular Therapeutix's E10

For the Biotechnology subindustry, Ocular Therapeutix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocular Therapeutix's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocular Therapeutix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ocular Therapeutix's Shiller PE Ratio falls into.



Ocular Therapeutix E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ocular Therapeutix's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.35/129.4194*129.4194
=-0.350

Current CPI (Dec. 2023) = 129.4194.

Ocular Therapeutix Quarterly Data

per share eps CPI Adj_EPS
201403 -2.450 99.695 -3.180
201406 -2.100 100.560 -2.703
201409 -0.480 100.428 -0.619
201412 -0.370 99.070 -0.483
201503 -0.350 99.621 -0.455
201506 -0.450 100.684 -0.578
201509 -0.470 100.392 -0.606
201512 -0.430 99.792 -0.558
201603 -0.440 100.470 -0.567
201606 -0.460 101.688 -0.585
201609 -0.390 101.861 -0.496
201612 -0.520 101.863 -0.661
201703 -0.580 102.862 -0.730
201706 -0.640 103.349 -0.801
201709 -0.540 104.136 -0.671
201712 -0.440 104.011 -0.547
201803 -0.400 105.290 -0.492
201806 -0.370 106.317 -0.450
201809 -0.380 106.507 -0.462
201812 -0.420 105.998 -0.513
201903 -0.450 107.251 -0.543
201906 -0.570 108.070 -0.683
201909 -0.450 108.329 -0.538
201912 -0.530 108.420 -0.633
202003 -0.410 108.902 -0.487
202006 -0.640 108.767 -0.762
202009 -0.210 109.815 -0.247
202012 -1.210 109.897 -1.425
202103 -0.240 111.754 -0.278
202106 -0.250 114.631 -0.282
202109 -0.230 115.734 -0.257
202112 -0.230 117.630 -0.253
202203 -0.220 121.301 -0.235
202206 -0.250 125.017 -0.259
202209 -0.310 125.227 -0.320
202212 -0.240 125.222 -0.248
202303 -0.390 127.348 -0.396
202306 -0.260 128.729 -0.261
202309 -0.250 129.860 -0.249
202312 -0.350 129.419 -0.350

Add all the adjusted EPS together and divide 10 will get our e10.


Ocular Therapeutix  (NAS:OCUL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ocular Therapeutix E10 Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocular Therapeutix (Ocular Therapeutix) Business Description

Traded in Other Exchanges
Address
24 Crosby Drive, Bedford, MA, USA, 01730
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Executives
Summer Road Llc 10 percent owner 207 6TH STREET, WEST PALM BEACH FL 33401
Antony C. Mattessich director C/O OCULAR THERAPEUTIX, INC., 34 CROSBY DR., SUITE 105, BEDFORD MA 01730
Adrienne L Graves director 125 STONE MOUNTAIN CIRCLE, NAPA CA 94558
Rabia Gurses Ozden officer: Chief Medical Officer C/O AKOUOS, INC., 645 SUMMER STREET SUITE 200, BOSTON MA 02210
Philip C. Strassburger officer: General Counsel 24 CROSBY DRIVE, BEDFORD MA 01730
Donald Notman officer: Chief Financial Officer C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Christopher G White officer: Chief Business Officer C/O AMAG PHARMACEUTICALS, INC., 1100 WINTER STREET, WALTHAM MA 02451
Jeffrey S. Heier director C/O OCULAR THERAPEUTIX, INC., 34 CROSBY DR., SUITE 105, BEDFORD MA 01730
Merilee Raines director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Lindstrom Richard L Md director 2811 WESTWOOD PL, WAYZATA MN 55391
Opaleye Management Inc. 10 percent owner ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108
Patricia Kitchen officer: Chief Operations Officer C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Leslie J. Williams director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Seung Suh Hong director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD MA 01730
Amarpreet Sawhney director, 10 percent owner, officer: President and CEO C/O OCULAR THERAPEUTIX, INC., 36 CROSBY DRIVE, SUITE 101, BEDFORD MA 01730